Category: Research Peptides | Reading time: 5 min | For research use only
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. Consisting of 15 amino acids, it has been the subject of extensive preclinical research since the 1990s, with studies examining its biological activity across a range of physiological systems.
This article summarizes the current state of BPC-157 research for scientific and educational purposes. All compounds discussed are strictly for laboratory and research use only.
Molecular Profile
- Full name: Body Protection Compound-157
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular weight: 1419.5 g/mol
- Form: Lyophilized powder (research grade)
- Stability: Stable at −20°C; sensitive to repeated freeze-thaw cycles
BPC-157 is notable for its stability in human gastric juice — an unusual property among peptides — which has made it a subject of interest in gastrointestinal research contexts.
Mechanisms Studied in Preclinical Research
Researchers have investigated several biological mechanisms associated with BPC-157 activity in animal models:
Angiogenesis pathways Multiple studies have observed BPC-157's association with upregulation of VEGF (vascular endothelial growth factor) expression. This has made it a compound of interest in preclinical models examining vascularization and tissue perfusion processes.
Nitric oxide system modulation Research has documented interactions between BPC-157 and the nitric oxide (NO) system, with studies in rodent models noting effects on NO synthesis pathways. This mechanism has been explored in the context of vascular and gastrointestinal research.
Growth hormone receptor interactions Preclinical data suggests BPC-157 may interact with growth hormone receptor pathways, which has prompted research interest in musculoskeletal and connective tissue models.
Tendon and ligament fibroblast activity In vitro studies have examined BPC-157's effect on tendon fibroblast proliferation and migration, with several publications reporting increased collagen synthesis markers in treated cell cultures.
Areas of Active Research
BPC-157 has appeared in peer-reviewed literature across several research domains:
Gastrointestinal research Given its origin as a gastric protein fragment, GI applications have been among the most studied. Animal models have examined its activity in models of inflammatory bowel conditions, gastric ulceration, and intestinal anastomosis healing.
Musculoskeletal models A substantial body of rodent research has examined BPC-157 in models involving tendon transection, ligament injury, and bone repair. Studies have reported histological findings suggesting accelerated organizational changes in treated tissue compared to controls.
Neurological research More recent preclinical literature has examined BPC-157 in models related to dopaminergic and serotonergic systems, with researchers investigating potential neuroprotective mechanisms in rodent models of neurotoxicity.
Wound healing models In vitro and in vivo wound models have been used to study BPC-157's effect on fibroblast activity, collagen deposition, and epithelial regeneration markers.
Key Published Research
The following peer-reviewed publications represent a cross-section of BPC-157 research:
- Sikiric P, et al. (2018). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.Current Neuropharmacology, 16(10), 1465–1503.
- Chang CH, et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774–780.
- Sikiric P, et al. (2016). Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. Current Pharmaceutical Design, 17(16), 1612–1632.
Research Considerations
BPC-157 remains an investigational compound with no approved clinical applications. All published data to date derives from in vitro studies and animal models. Human clinical trial data is limited, and researchers should evaluate the existing literature critically and in full.
Purity and batch consistency are critical variables in peptide research. Researchers should source BPC-157 from suppliers providing third-party verified Certificates of Analysis (COA) with HPLC purity data.
All products and information provided by NordBioLab are strictly for scientific research and laboratory use only. Not for human or veterinary consumption. This article does not constitute medical advice.